en

PRODUCT DETAIL

Qoyvolma 130 mg koncentrát na infúzny roztok

Code 0340F
MA number EU/1/25/1925/003
Product Form: con inf 1x26 ml/130 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Celltrion Healthcare Hungary Kft., Hungary
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC05 Ustekinumab
Shelf life: 36
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 02.06.2025
Validity: 02.06.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 23.06.2025
eu-flag.png sk-flag.png